- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00513903
Expanding the Role of Pharmacists in Treating Persons With Cardiovascular or Lung Diseases (IowaCOC)
Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Drugs used to treat cardiovascular and lung diseases are the most frequent cause of hospitalizations and emergency department visits related to inadequate therapy or ADEs. ADEs occur in 25% of patients who are able to walk and may cause up to 17% of hospital admissions among the elderly. A lack of communication and coordination between the hospital setting and the patient's own community setting, upon patient discharge, may contribute to the high number of ADEs. By expanding the role of pharmacists and encouraging communication between hospitals and pharmacists, the number of ADEs may be reduced. There have been a few small studies that have examined the way patient information is transferred between hospital and community pharmacists, but these studies did not involve the patients' primary care physicians nor did they fully evaluate the effect of communication between hospital and community pharmacists. The purpose of this study is to evaluate the effectiveness of providing a pharmacist case manager to hospitalized patients with cardiovascular or lung disease at reducing the number of ADEs, re-hospitalizations, and unscheduled medical visits.
This study will enroll individuals with certain conditions or diseases who are admitted to the hospital. Participants will be randomly assigned to either a control group, a minimal treatment group, or an enhanced treatment group. Participants in the minimal and enhanced treatment groups will meet with a pharmacist case manager while in the hospital to conduct a medication history review. The case manager will also meet with participants at the time of hospital discharge and provide them with a discharge summary and educational materials. Additionally, for participants in the enhanced treatment group, the case manager will do the following: transfer the discharge summary data to the participant's community physician and pharmacist; call the participant 3 to 5 days following discharge from the hospital and as needed thereafter to resolve medication problems; and communicate with and make recommendations to the participant's community physician and pharmacist. All participants will meet with a study research nurse immediately after study entry to complete questionnaires. Study nurses will also call all participants 30 and 90 days following hospital discharge to collect adverse event information. Surveys will be completed by each participant's pharmacist and primary care physician 90 days following the participant's discharge from the hospital.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Fase 3
Kontakter og lokationer
Studiesteder
-
-
Iowa
-
Iowa City, Iowa, Forenede Stater, 52242
- The University of Iowa
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Speaks either English or Spanish
- Willing to obtain all long-term prescriptions from one community pharmacy during the 90-day study period
- Diagnosed with at least one of the following conditions: high blood pressure, hyperlipidemia, heart failure, coronary artery disease, heart attack, stroke, transient ischemic attack, asthma, chronic obstructive pulmonary disease (COPD), diabetes, or receiving oral anticoagulation therapy
- Admitted to the general medicine, family medicine, cardiology, or orthopedics services hospital department
Exclusion Criteria:
- Does not have a working telephone
- Has a hearing impairment that does not allow the use of a telephone
- Enrolled in Iowa Care (i.e., individual has no community physician or community pharmacist following hospital discharge)
- Life expectancy estimated at less than 6 months at the time of study entry
- Dementia or cognitive impairment
- Severe psychiatric or psychosocial factors, including substance abuse, that may impair the desire or ability to complete all aspects of the study
- Admission to the psychiatric, surgery, or hematology/oncology services hospital department
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Minimal intervention
Minimal intervention group patients will be seen by a clinical pharmacist in the hospital but will not receive followup after hospital discharge.
|
Minimal intervention patients will be seen by a clinical pharmacist during the hospitalization period to improve continuity of pharmacy care following hospital discharge.
|
Eksperimentel: Enhanced intervention
Enhanced intervention patients will receive care from a clinical pharmacist during hospitalization and followup by phone after hospitalization.
|
Enhanced intervention patients will be visited in the hospital and will also be called by the clinical pharmacist following discharge to follow-up on any problems that might have developed after discharge.
|
Ingen indgriben: Control
Control arm patients will not be seen by the clinical pharmacist.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
ADEs
Tidsramme: Measured 30 and 90 days after hospital discharge
|
Measured 30 and 90 days after hospital discharge
|
Medication appropriateness
Tidsramme: Measured 30 and 90 days after hospital discharge by the Hanlon et al. Medication Appropriateness Index
|
Measured 30 and 90 days after hospital discharge by the Hanlon et al. Medication Appropriateness Index
|
Complications related to medications, including the number of hospital readmissions, unscheduled visits to emergency departments or urgent care facilities, and physician visits related to a medication problem or ADE
Tidsramme: Measured 30 and 90 days after hospital discharge
|
Measured 30 and 90 days after hospital discharge
|
Cost-effectiveness of the minimal or enhanced treatment compared to usual care
Tidsramme: Measured 30 and 90 days after hospital discharge
|
Measured 30 and 90 days after hospital discharge
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Number of medications
Tidsramme: Measured 30 and 90 days after hospital discharge
|
Measured 30 and 90 days after hospital discharge
|
Complete medication list
Tidsramme: Measured 30 and 90 days after hospital discharge
|
Measured 30 and 90 days after hospital discharge
|
Community physician and pharmacist surveys
Tidsramme: Measured 90 days after participant's hospital discharge
|
Measured 90 days after participant's hospital discharge
|
Medication adherence
Tidsramme: Measured 30 and 90 days after hospital discharge
|
Measured 30 and 90 days after hospital discharge
|
Barriers to patient adherence
Tidsramme: Measured at baseline by scores on the following questionnaires: self-efficacy, cognitive impairment (Pfeiffer Mental Status Questionnaire), medication management skills and the Katz index of activities of daily living
|
Measured at baseline by scores on the following questionnaires: self-efficacy, cognitive impairment (Pfeiffer Mental Status Questionnaire), medication management skills and the Katz index of activities of daily living
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Barry L. Carter, PharmD, University of Iowa
Publikationer og nyttige links
Generelle publikationer
- Carter BL, Farris KB, Abramowitz PW, Weetman DB, Kaboli PJ, Dawson JD, James PA, Christensen AJ, Brooks JM. The Iowa Continuity of Care study: Background and methods. Am J Health Syst Pharm. 2008 Sep 1;65(17):1631-42. doi: 10.2146/ajhp070600.
- Farley TM, Shelsky C, Powell S, Farris KB, Carter BL. Effect of clinical pharmacist intervention on medication discrepancies following hospital discharge. Int J Clin Pharm. 2014 Apr;36(2):430-7. doi: 10.1007/s11096-014-9917-x. Epub 2014 Feb 11.
- Israel EN, Farley TM, Farris KB, Carter BL. Underutilization of cardiovascular medications: effect of a continuity-of-care program. Am J Health Syst Pharm. 2013 Sep 15;70(18):1592-600. doi: 10.2146/ajhp120786.
- Anderegg SV, Demik DE, Carter BL, Dawson JD, Farris K, Shelsky C, Kaboli P. Acceptance of recommendations by inpatient pharmacy case managers: unintended consequences of hospitalist and specialist care. Pharmacotherapy. 2013 Jan;33(1):11-21. doi: 10.1002/phar.1164.
- Farris KB, Carter BL, Xu Y, Dawson JD, Shelsky C, Weetman DB, Kaboli PJ, James PA, Christensen AJ, Brooks JM. Effect of a care transition intervention by pharmacists: an RCT. BMC Health Serv Res. 2014 Sep 18;14:406. doi: 10.1186/1472-6963-14-406.
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 498
- R01HL082711 (U.S. NIH-bevilling/kontrakt)
- R01HL082711-01A2 (U.S. NIH-bevilling/kontrakt)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Hjerte-kar-sygdomme
-
Ottawa Hospital Research InstituteAfsluttetStress | Crisis Resource Management (CRM) færdigheder | Advanced Cardiovascular Life Support (ACLS) færdighederCanada
Kliniske forsøg med Minimal intervention
-
Dara SorkinAfsluttetDepression | Post traumatisk stress syndrom
-
The University of Hong KongAktiv, ikke rekrutterendePræ-diabetesHong Kong
-
Heinen und Löwenstein GmbH & Co. KGUkendtObstruktiv søvnapnøTyskland
-
Oregon Research InstituteAfsluttet
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Hvidovre University... og andre samarbejdspartnereRekrutteringFemoroacetabulært impingementsyndromDanmark, Australien
-
Rolando Giovanni Díaz ZavalaRekrutteringFedme | Overvægtig | VægtøgningMexico
-
Jessa HospitalHasselt UniversityAfsluttetDelirium | Postoperativ kognitiv dysfunktion | Cerebrovaskulær ulykkeBelgien
-
Institut Català d'OncologiaUkendtTilbagevenden | BrystneoplasmerSpanien
-
University Hospital Inselspital, BerneUniversity of Zurich; Swiss National Science Foundation; University of BernAfsluttetMyokardieinfarkt | Stresslidelser, posttraumatiskSchweiz
-
St George Hospital, AustraliaAfsluttet24-timers Pad Test Vægtøgning med og uden aktivitet